Pressurized Intraperitoneal Aerosol Chemotherapy: The Road from Promise to Proof
SourceClinical Cancer Research, 27, 7, (2021), pp. 1830-1832
Article / Letter to editor
Display more detailsDisplay less details
Clinical Cancer Research
SubjectRadboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an innovative drug delivery technique invented to be used for the treatment of peritoneal metastasis. Its application gained popularity over the past years. Several prospective clinical trials are being conducted to determine efficacy and safety. At this moment, there remain many challenges to overcome before PIPAC can be widely adopted in clinical practice.See related article by Kim et al., p. 1875.
Upload full text